haematology
Medicopolitical news

News in Brief: Interim PET interval predicts R-CHOP treatment failure in DLBCL; Four myeloma drugs make bid for PBS listing; Call for Medicare review of procedural specialist incomes

Interim PET interval predicts R-CHOP treatment failure in DLBCL Australian haematologists have identified an interim FDG-PET method for predicting response to R-CHOP chemotherapy in DLBCL that’s been shown to improve on existing scoring systems. The findings have bolstered evidence for the prognostic relevance of iPET, which has been controversial without consensus on the most appropriate ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic